There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Illumina Inc. (ILMN) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by +$2.3, or +1.18%, to $197. Volume reached 84,804 shares, with price reaching a high of $199 and a low of $196.99. Earlier, Yahoo Finance discussed this stock as it revealed John Hancock becomes the first life insurance carrier to offer access to GRAIL’s multi-cancer early detection test to customers.
This NASDAQ-listed company operates within the Diagnostics & Research industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $198.17 and fluctuated between $207.00 as its day high and $195.11 as its day low. The current market capitalization of Illumina Inc. is $31.46B. A total of 2.32 million shares were traded on the day, compared to an average of 1.51M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, ILMN has seen 0 BUY and 2 SELL insider trades, representing the acquisition of 0 and the disposition of 824 shares. Over the last 12 months, there were 26 BUYs and 68 SELLs from insiders. Insiders purchased 73,250 shares during that period but sold 49,618.
In the most recent transaction, Aravanis Alexander sold 539 shares of ILMN for 200.00 per share on Jul 07. After the transaction, the SVP, Chief Technology Officer now owns 3,346 company shares. In a previous transaction on Jun 10, TOUSI SUSAN H sold 250 shares at 214.85 per share. ILMN shares that SVP, Chief Commercial Officer owns now total 41,833.
Among the insiders who sold shares, Dadswell Charles disposed of 368 shares on Apr 28 at a per-share price of $300.13. This resulted in the SVP & General Counsel holding 7,427 shares of ILMN after the transaction. In another insider transaction, Hoyt Aimee L sold 2,474 shares at $350.51 per share on Apr 12. Company shares held by the SVP, Chief People Officer now total 5,342.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for ILMN in the last 3 months, the mean price target is $242.69 with high estimates of $380.00 and low estimates of $130.00. In terms of 52-week highs and lows, ILMN has a high of $442.54 and a low of $173.45.
As of this writing, ILMN has an earnings estimate of $0.28 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of $0.32 per share and a lower estimate of $0.27. The company reported an EPS of $0.57 in the last quarter, which was -9.52% lower than expectations of $0.63.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 18 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ILMN is Underweight with a score of 3.40. A total of 4 analysts rated the stock as Buy while 1 rated it as Overweight while 10 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 3 thought it should be Sold.